Selected article for: "group cat and study period end"

Author: Sugiarto, Sarah; Spiri, Andrea M.; Riond, Barbara; Novacco, Marilisa; Oestmann, Angelina; de Miranda, Luisa H. Monteiro; Meli, Marina L.; Boretti, Felicitas S.; Hofmann-Lehmann, Regina; Willi, Barbara
Title: Passive immunization does not provide protection against experimental infection with Mycoplasma haemofelis
  • Document date: 2016_8_5
  • ID: 1uw8xcxw_14
    Snippet: For the main experiment, the recipient cats were assigned to two groups: group A (n = 10, passive immunization, cats DHR1, DHR2, JHW1, JHW2, JHW4, JHW5, JHX1, JHX2, JHZ1 and JIC1) and group B (n = 5, control group, cats DHP1, DHT1, JHV1, JHW3 and JIC2). The cats of each group were housed together during and after the end of the study period. On day 0, plasma transfusion was performed, and the cats were experimentally inoculated with Mhf. For the .....
    Document: For the main experiment, the recipient cats were assigned to two groups: group A (n = 10, passive immunization, cats DHR1, DHR2, JHW1, JHW2, JHW4, JHW5, JHX1, JHX2, JHZ1 and JIC1) and group B (n = 5, control group, cats DHP1, DHT1, JHV1, JHW3 and JIC2). The cats of each group were housed together during and after the end of the study period. On day 0, plasma transfusion was performed, and the cats were experimentally inoculated with Mhf. For the passive immunization, each cat in group A was transfused with a 9 mL aliquot of plasma pool A. Each cat in group B was transfused with a 9 mL aliquot of plasma pool B. Ten minutes after the completion of the transfusion, all cats in groups A and B were inoculated with Mhf by a subcutaneous injection of 10 µL of 20% dimethyl sulfoxide (DMSO)-preserved blood containing 10 3 copies of Mhf diluted with 90 µL of phosphatebuffered saline (PBS), as previously described [22] . An aliquot of the same Mhf inoculum was used to infect the recipient cats in this study that had been used to infect the plasma donor cats (HBU2, HBZ2 and HCD2) in a previous study [28] . Clinical condition, body temperature and body weight were recorded, and blood samples collected prior to plasma transfusion and Mhf inoculation (day 0), twice weekly post inoculation (pi) until week 7 and weekly thereafter up to day 100 pi.; an additional blood collection to measure red blood cell (RBC) osmotic fragility (OF) was performed on day 179 pi because RBC OF was still increased compared with baseline values in several cats of group A and B at day 100 pi. All samples were collected without anesthesia, with the exception of the samples collected at day 0. Samples for PCR analysis and serology were stored at −80 °C until analysis. Flow cytometry, hematology, blood biochemistry, Coombs tests and RBC OF assays were carried out within 4 h of blood collection.

    Search related documents:
    Co phrase search for related documents
    • baseline value and body weight: 1, 2, 3, 4
    • baseline value and control group: 1, 2, 3, 4, 5, 6, 7, 8
    • blood biochemistry and body temperature: 1, 2, 3, 4, 5, 6, 7
    • blood biochemistry and body weight: 1, 2, 3, 4, 5
    • blood biochemistry and clinical condition: 1
    • blood biochemistry and control group: 1, 2, 3, 4, 5, 6, 7, 8
    • blood cell and body temperature: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood cell and body weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • blood cell and clinical condition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • blood cell and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood collection and body temperature: 1, 2, 3
    • blood collection and body weight: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • blood collection and clinical condition: 1
    • blood collection and control group: 1, 2, 3, 4, 5
    • blood sample and body temperature: 1, 2, 3
    • blood sample and body weight: 1, 2, 3, 4, 5, 6, 7, 8
    • blood sample and clinical condition: 1, 2, 3
    • blood sample and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • body temperature and clinical condition: 1, 2, 3, 4, 5